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Original Article
Chronic anemia due to gastrointestinal bleeding:
when do gastroenterologists transfuse?
KV Grooteman1, EJM van Geenen1, W Kievit2 and JPH Drenth1
Abstract
Background: The hypothesis is that decision-making for transfusion varies considerably among gastroenterologists. The aim
is to identify preferences and predictors of transfusion decision-making in chronic anemia.
Study design and methods: Between February and April of 2015, a computerized adaptive choice-based conjoint survey was
administered to gastroenterologists in the Netherlands. The survey included seven patient attributes: hemoglobin levels,
hemoglobin stability, age, iron indices, the presence of anemia-related symptoms, cardiovascular comorbidities, and the
number of transfusions in the past half year. Predictors of transfusion preferences were assessed by multivariable regression.
Results: 113 gastroenterologists completed the survey (response rate¼ 29%; mean age¼ 47 years; 24% women). Absolute
hemoglobin level was the most important incentive of transfusion, accounting for 42% of decision-making, followed by age
(15%), hemoglobin stability (12%), anemia-related symptoms (10%), and cardiovascular comorbidities (10%). A hemoglo-
bin level >9.6 g/dL is an inflection point, where gastroenterologists would not prescribe transfusions. Age of the patient is
more important in the decision-making process to younger gastroenterologists (OR 2.9, 95% CI 5.3 to 0.5).
Conclusion: Absolute hemoglobin level is the most important factor to transfusion decision-making. This is contradictory to
transfusion guidelines for chronic anemia which address the importance of symptoms.
Keywords
Chronic anemia, transfusion practices, gastrointestinal bleeding, decision-making, adaptive choice-based conjoint analysis
Received: 25 August 2016; accepted: 22 January 2017
Introduction
Iron deﬁciency anemia is a common problem in gastro-
enterology practices and is associated with lethargy,
weakness, dyspnea, and a decreased quality of life.1,2
Therefore, treatment of iron deﬁciency anemia is
important to improve the related symptoms. Apart
from treating the underlying cause, iron supplementa-
tion and/or red blood cell (RBC) transfusions can be
given to restore hemoglobin (Hb) level. However, both
undertreatment and overtreatment of anemia are asso-
ciated with impaired clinical outcomes.3 Therefore, a
targeted transfusion regimen with clear deﬁned rules
in each patient is the best route to an increased quality
of life and clinical outcome.4
RBC transfusion strategies have become more
restricted over the past decade.5 American, European,
and Australian transfusion guidelines for patients with
chronic anemia advise transfusion in case of clinical
symptoms and below deﬁned Hb level thresholds.6–8
There is no literature published on transfusion practices
in gastroenterology, but it is known that there is a wide
variation in transfusion practices in perioperative care
and critical care patients.9
It is unknown which clinical factors determine the
decision-making process, when and who to transfuse or
whether there are diﬀerences between gastroenterolo-
gists. This decision-making process is complex and
although there are guidelines, the interpretation of
these guidelines in clinical practice might diﬀer between
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healthcare professionals. As a corollary we hypothesize
that transfusion preferences vary, but that certain
gastroenterologists’ characteristics predict behaviors
such as gender, years of experience, type of hospital,
or subspecialization. More insight in the understanding
of and reasons for variation in transfusion practices
could lead to targeted strategies to increase awareness
among gastroenterologists to adequately prescribe
RBC transfusions.
The aim of this study is to identify factors that trig-
ger the use of transfusions in chronic anemia due to
gastrointestinal bleeding and characterize the hetero-
geneity among gastroenterologists regarding transfu-
sion decision-making through a nationwide survey
using the adaptive choice-based conjoint (ACBC) ana-
lysis technique.
Materials and methods
Study setting
We administered a survey to every gastroenterologist
aﬃliated with the Dutch Association of
Gastroenterologists. Over 98% of active gastroenter-
ologists in the Netherlands are member of the Dutch
Association of Gastroenterologists. In total, 395
gastroenterologists were invited to participate in this
anonymous survey. The survey was sent to invitees by
e-mail between February and April 2015, with a remin-
der up to two times to initial non-responders.
Overview of ACBC analysis
Conjoint analysis is a quantitative method originally
developed in applied sciences which can be used to
evaluate clinical decision-making in healthcare.10–17
Full control of potentially confounding factors can be
achieved by having each participant evaluate the same
clinical factors with according levels. As such, conjoint
analysis is considered as a good method to eﬀectively
analyze decision-making in clinical medicine.18
Compared with other methods to investigate decision
making, such as self-report or absolute ranking of fac-
tors, ACBC is more eﬀective in approximating the real
world.19,20 Because the decision to transfuse depends on
complex combinations of clinical factors that may be
interdependent and are weighed by the individual
gastroenterologists, ACBC is a good method to inves-
tigate this decision-making process.
The administered survey consists of two parts: the
ACBC analysis and a set of stand-alone questions
regarding provider demographics and practice charac-
teristics. The seven evaluated clinical factors in the
ACBC analysis are: Hb level, Hb stability, age, iron
indices, the presence of anemia-related symptoms,
cardiovascular comorbidities, and the number of trans-
fusions in the past half year. Triggers of transfusion
were studied in a scenario of chronic anemia due to
gastrointestinal bleeding from angiodysplasias. This
scenario was not changed as we do not want to study
the underlying disease as a clinical factor, because this
is not a trigger according to the guidelines.6–8,21,22
The case vignettes were designed on the basis of a
fractional factorial design that ensures the absence of
collinearity. For each case vignette, the gastroenterolo-
gist was asked to indicate whether he or she would give
a blood transfusion (yes or no) according to the seven
predeﬁned clinical patient characteristics that are rele-
vant for the decision (Table 1). Respondents must
choose a preferred level for each clinical characteristic
to a degree that allows identiﬁcation of a threshold that
triggers activity (e.g., Hb level, fatigue, comorbidities,
etc.). Then sets of two hypothetical patient proﬁles were
Table 1. Clinical factors and levels tested in conjoint analysis
clinical vignettes.
Clinical factor Levels
Hemoglobin level (g/dL) 9.6–11.3
8.0–9.5
6.4–7.9
<6.4
Hemoglobin stability No change in hemoglobin level
over the past month
1.6 g/dL drop over the past month
0.8 g/dL drop over the past week
1.6 g/dL drop over the past week
Age (years) <25
25–50
50–70
>70
Iron indices No iron deficiency
Iron deficiency (e.g. serum ferritin
<100 mg/L, TSAT <16%)
Anemia-related symptomsa No
Yes
Cardiovascular comorbiditiesb No
Yes
Number of RBC transfusions
in the past half year
0–2
3–5
5–10
>10
TSAT, transferrin saturation.
aAnemia-related symptoms: fatigue and dyspnea.
bCoronary artery disease, peripheral artery disease, cerebrovascular
accident, or myocardial infarction.
968 United European Gastroenterology Journal 5(7)
presented and gastroenterologists were asked to select
the patient that he/she would transfuse (Figure 1).
Based on the choices made, the comparisons become
increasingly complex as the exercise continues. The
ACBC method ranks the respondent’s prioritization
of clinical factors that inﬂuence the decision to
transfuse.
Survey design
To ensure that the survey adequately queried clinical
factors related to RBC transfusion decision-making, we
used the British, Dutch and American transfusion
guidelines that were current at the time of the
survey.6,7,21 Moreover, we piloted the validity of
clinical characteristics in a small (n¼ 8) group of
gastroenterologists. The pilot group also advised to
include number of transfusions in the past half year
as a variable. This process further reﬁned the case vign-
ettes and the levels of clinical factors.
Sample size and statistical analysis
The speciﬁc sample size for conjoint analysis (n) should
satisfy the equation (nta)/c 500, where t is the number
of tasks, a is the number of alternatives per task, and c
is the maximum number of levels for a given attribute.10
In this survey, providers completed t¼ 6 tasks with an
average a¼ 3 alternatives and c 4 levels, based on
these parameters a sample size of 110 can be considered
suﬃcient.
The main outcomes are utilities. The utilities indicate
how much the diﬀerence between the levels of one attri-
bute aﬀects the decision to transfuse. Across the levels
of one attribute the utilities add up to 0, which leads to
a middle weight around 0. Negative utilities for a cer-
tain level do not trigger gastroenterologists to prescribe
a transfusion compared to positive utilities, where
gastroenterologists do want to prescribe a transfusion.
Hierarchical Bayes analysis is used to calculate
individual importance for each of the seven clinical fac-
tors. The relative importance shows the contribution in
percentage of each individual factor relative to the
other factors and together they make up 100% of the
decision-making. This results in a rank order of the
seven clinical factors from most to least important
together. We performed descriptive analyses to calcu-
late means and proportions for the gastroenterologist
characteristics.
We aimed to predict decision-making behavior (the
dependent variable) using clinical factors and their
levels as independent variables. We conducted multi-
variable linear regression analysis to determine if
gastroenterologist or practice type characteristics (sex,
age, years as a specialist, subspecialization, and type of
hospital) predicted individual importance for each of
the seven tested clinical factors. Factors were included
if the p-value was <0.2 in univariate analysis.
Both patients are known with chronic anemia due to occult gastrointestinal bleeding of small
bowel angiodysplasias. Which patient would you give the RBC transfusion? 
Hemoglobin value 8.0–9.5 g/dL 9.6–11.3 g/dL
Hemoglobin stability Decrease of 1.6 g/dL in the past week No Hb decrease in the past month
Age 50–70 years 50–70 years
Anemia symptoms Symptoms present Symptoms present
Cardiovascular
Comorbidity in Hx
Iron status No iron deficiency Iron deficient
Nr. of transfusions in
past half year 
5–10 transfusions 5–10 transfusions
Present Absent
Figure 1. Example of a case vignette.
Anemia-related symptoms: fatigue and dyspnea
Cardiovascular comorbidity in the past: coronary artery disease, peripheral artery disease, cerebrovascular accident, or myocardial
infarction.
Iron deficiency present: serum ferritin <100mg/L with transferrin saturation <16%.
Hx, history; Nr., number.
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Continues independent variables were transformed in
binary variables by using the mean /median. For each
of these gastroenterologists’ characteristics the associ-
ation with the individual importance scores of the seven
clinical patient factors was calculated by the odds ratio
(OR) with 95% conﬁdence intervals (95% CIs). The
part-worth utility analyses and individual attribute
importance values are automatically calculated by the
Sawtooth Software (North Orem, UT, USA). The
regression analysis was performed with SPSS
Statistics software version 22.0 (IBM, Armonk, NY,
USA).
Results
Characteristics of responders
A total of 113/395 (29%) gastroenterologists completed
the survey. Seventy-six percent of the responders were
male (Table 2). Mean age was 47 years (SD 9) with a
mean duration of 13 years (SD 10) of being a specialist.
Most gastroenterologists (n¼ 54, 49%) worked in a
teaching hospital. The most prevalent subspecializa-
tions were advanced endoscopy (n¼ 27, 24%) and
inﬂammatory bowel disease (n¼ 23, 21%).
Rank order of clinical factors
Of the seven attributes assessed, absolute Hb level is the
most important incentive for transfusion, accounting
for 42% of decision-making, followed by age (15%),
Hb stability (12%), anemia-related symptoms (10%),
cardiovascular comorbidities (10%), the number of
transfusions in the past half year (6%), and iron indices
(5%) (see Supplementary ﬁgure 1 online).
Inflection points of clinical factors
The inﬂection point is the point where the utility of a
speciﬁc level increases or decreases signiﬁcantly com-
pared to the other levels of the clinical factor. For Hb
level the inﬂection point is 9.6 g/dL, above which phys-
icians do not prescribe transfusions (Supplementary
ﬁgure 2). Inﬂection points of the other clinical factors
were also calculated (Supplementary ﬁgure 3). Hb sta-
bility is only an important clinical factor in the decision-
making process when the extremes are true, which were
noHb change or a 1.6 g/dL drop over the past week. The
average part-worth utilities for the diﬀerent levels
(stable, 1.6 g/dL drop over the past month, 0.8 g/dL
drop over the past week, 1.6 g/dL drop over the
past week) are respectively 37 (SD 18), 1 (SD 20),
0 (SD 15), and 36 (SD 35). The inﬂection point for age
of the patient is 25 years, e.g. below this age gastroenter-
ologists are not triggered to prescribe transfusions.
Preferences for transfusion dependent on
gastroenterologist characteristics
In multivariable linear regression, age of the gastro-
enterologists was a predictor for the importance in deci-
sion-making process of the patient’s characteristic age
(OR 2.9, 95% CI 5.3 to 0.5). Younger gastroenter-
ologists (<47 years) value the patient’s age 2.9 times
more than older gastroenterologists in their decision-
making process to transfuse. Sex, type of hospital,
and subspecialization were not predictors in multivari-
able regression analysis for the importance of any of the
seven clinical factors in the decision-making process.
Discussion
This study provides insight in the decision-making
process concerning RBC transfusion in everyday
gastrointestinal practice. Of all clinical factors, absolute
Hb level is the most important incentive of RBC trans-
fusion in patients with chronic anemia. The inﬂection
point in decision making is an Hb level of 9.6 g/dL,
above which gastroenterologists are averse in prescrib-
ing RBC transfusions. Symptoms, age of the patient
and iron indices are less important in the decision
making process. Transfusion preferences are dependent
on the gastroenterologists’ age.
This variation between gastroenterologists in trans-
fusion strategies is similar to data from other studies
investigating transfusion strategies in other ﬁelds of
medicine.9,10 However, the relative minor impact of
patient’s age and symptoms on the decision-making
Table 2. Gastroenterologists characteristics (n¼ 113).
Characteristic Number (%)
Sex: male 86 (76)
Age (years) 47, SD 9
Mean duration specialist (years) 13, SD 10
Type of hospital
University hospital 25 (22)
Teaching hospital 53 (47)
Non-teaching hospital 35 (31)
Subspecialization (n¼ 111)
Advanced endoscopy 27 (24)
Inflammatory bowel disease 23 (21)
Oncology 17 (15)
Hepatology 9 (8)
None 25 (23)
Other 10 (9)
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process in our study, is not in line with American,
European and Australian RBC transfusion guide-
lines.6–8,21,22 The guidelines advise to integrate Hb
levels with data on symptoms, age and iron indices,
while our respondents were mainly guided by absolute
Hb levels (Table 3). Possible explanations for non-
adherence are a lack of awareness of the new guidelines,
low exposure rate of deciding to prescribe a RBC trans-
fusion by the specialist gastroenterologists themselves
or diﬃculty with the interpretation of the recommen-
dations (e.g. what is considered as cardiovascular
comorbidity).6,21 This hypothesis of lack of awareness
and low exposure rate by the specialist is supported by
our ﬁnding that younger gastroenterologists value the
clinical factors recommended in the guidelines (e.g. age)
more than the older gastroenterologists.
The present study comes with limitations. First, we
determined the clinical factors and the corresponding
levels used in this ACBC analysis technique by using
the guidelines and pilot testing for comprehensibility.
However, there may be unidentiﬁed factors that
inﬂuence the decision-making process. For example,
our survey did not oﬀer parenteral iron supplementa-
tion as an option to treat anemia. In daily clinical prac-
tice RBC transfusion can be preceded by parenteral
iron. This may increase the likelihood of measurement
error, which could have led to a higher inﬂection point
of Hb for RBC transfusion than in real life. Second,
there is a risk of response bias due to the relatively low
response rate (29%). We do not know the speciﬁc
reasons for non-response, but to assess if there are
systematic diﬀerences we compared respectively
Table 3. Guidelines recommending transfusion strategies in (chronic) anemia.a
Guidelines Year
Impact
factor
journal
Grilli
scoreb Topic Recommendations
American Association of
Blood Banks6
2012 17.8 4 RBC transfusion - restrictive transfusion strategy (7–8 g/dL)
in hospitalized, stable patients
- transfusion decision may be influenced
by symptoms and Hb concentration
American Society of
Anesthesiologists task
force22
1996 5.9 4 Blood component
therapy
- RBC transfusion is rarely indicated when
Hb 10 g/dL and is almost always indi-
cated when Hb 6 g/dL
- when Hb 6–10 g/dL decision should be
based on the risk of complications of
inadequate oxygenation
British Committee for
Standards in
Haematology7
2001 5.0 1 RBC transfusion - based on patients’ symptoms (using
functional assessment scales)
- there is no universal trigger (e.g. Hb) for
RBC transfusion
Australian and
New Zealand Society of
Blood Transfusion8
2001 - 2 RBC transfusion - the decision to transfuse RBC should be
based on clinical assessment incl. symp-
toms, reaction previous transfusion and
Hb level
- RBC when Hb is> 10 g/dL is
inappropriate
Dutch Blood Transfusion
Guideline21
2011 7.9 4 Blood transfusions - strict indications for RBC are symptom-
atic anemia or Hb< 4.8 g/dL
- decision for prophylactic RBC should be
based on Hb-level in combination with
age and cardiopulmonary comorbidity
National Comprehensive
Cancer Network1
2012 4.2 3 Cancer- and chemotherapy-
induced anemia
- no transfusion in asymptomatic patients
without significant comorbidities
- transfusion is indicated in the presence
of symptoms
- in asymptomatic patients with severe
comorbidities the Hb goal is 7–9 g/dL
RBC, red blood cell; Hb, hemoglobin; incl., including.
aGuidelines addressing perioperative care, critically ill patients or children are excluded.
bGrilli score: quality assessment tool for guidelines addressing three topics: description of the involved professionals, description of the sources of
information, and explicit grading of evidence. Score range: 0–4.
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characteristics of responders and members of the Dutch
Association of Gastroenterologists. Sex (76% vs. 71%
men), experience (13 vs. 13 years as a consultant), and
type of hospital (academic 21 vs. 22%, teaching hos-
pital 49 vs.39%) are comparable between the two
groups, which lowers the chance of a large non-
response bias in this study. Moreover, the response
rate in our study is comparable to other surveys.23
As this study is designed to get insight in the deci-
sion-making process, we can only speculate about the
underlying causes for the discrepancy with guidelines.
Further research should be performed to investigate the
causes of non-adherence. This is study however is the
ﬁrst step in understanding the decision-making. This is
important to instigate the debate about the correct use
of RBC transfusion, which eventually should lead to
strategies to improve guideline awareness and adher-
ence. Ultimately, this might decrease the undertreat-
ment and overtreatment of chronic anemia with an
improvement of clinical outcomes and quality of life.
To conclude, absolute Hb level trumps all other fac-
tors as the most important trigger to RBC transfusion
decision-making. Current transfusion guidelines
address the importance of other factors like the pres-
ence of symptoms.1,6,7,8,21 This discrepancy might
reﬂect a lack of awareness of these guidelines by
gastroenterologists.
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